每日投资策略：市场信心改善，港股有望挑战2万3-20250319

Group 1: Market Overview - The Hong Kong stock market showed significant improvement, with the Hang Seng Index rising by 805 points or 3.7%, closing at 22,620, the highest since October 7 of the previous year [3] - The market's positive momentum was driven by technology stocks, with Tencent and Alibaba seeing substantial gains of 7.4% and 6.3% respectively [3] - The overall market turnover reached 364.6 billion HKD, indicating strong trading activity [3] Group 2: Economic Outlook - Lin Yifu, a prominent economist, predicts that China's economy in 2025 will be better than in 2024, continuing the recovery trend initiated by policies announced in September 2024 [6] - He emphasized that China's per capita GDP reached 13,445 USD in 2024, just 4% shy of the World Bank's high-income threshold of 14,005 USD, suggesting that achieving a 5% growth in 2025 could help China cross this threshold [6][7] - Lin also noted that while challenges exist, the opportunities for economic growth in China outweigh the risks [6] Group 3: Company Developments - Kingsoft Biotechnology anticipates a significant increase in net profit for the year ending December 2024, primarily due to a one-time unrealized gain of approximately 3.2 billion USD from the sale of Legend Biotech [13] - The company also reported a non-cash fair value loss of about 124 million USD related to its A and C class preferred shares, but adjusted net profit remained stable [13] - KGI International plans to apply for regulatory approval to offer virtual asset trading services, aiming to diversify its service offerings and attract a broader customer base [11]